- Home
- GV vs GTBP Comparison
GV vs GTBP Comparison
Compare GV & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GV
- GTBP
- Stock Information
- Founded
- GV 2013
- GTBP 1965
- Country
- GV Canada
- GTBP United States
- Employees
- GV N/A
- GTBP N/A
- Industry
- GV Other Consumer Services
- GTBP Biotechnology: Pharmaceutical Preparations
- Sector
- GV Real Estate
- GTBP Health Care
- Exchange
- GV Nasdaq
- GTBP Nasdaq
- Market Cap
- GV 5.7M
- GTBP 6.6M
- IPO Year
- GV 2022
- GTBP N/A
- Fundamental
- Price
- GV $2.15
- GTBP $2.48
- Analyst Decision
- GV
- GTBP Strong Buy
- Analyst Count
- GV 0
- GTBP 1
- Target Price
- GV N/A
- GTBP $11.00
- AVG Volume (30 Days)
- GV 275.6K
- GTBP 22.2K
- Earning Date
- GV 12-24-2024
- GTBP 11-14-2024
- Dividend Yield
- GV N/A
- GTBP N/A
- EPS Growth
- GV N/A
- GTBP N/A
- EPS
- GV 0.32
- GTBP N/A
- Revenue
- GV $9,380,985.00
- GTBP N/A
- Revenue This Year
- GV N/A
- GTBP N/A
- Revenue Next Year
- GV N/A
- GTBP N/A
- P/E Ratio
- GV $5.21
- GTBP N/A
- Revenue Growth
- GV 11.25
- GTBP N/A
- 52 Week Low
- GV $1.00
- GTBP $1.92
- 52 Week High
- GV $8.85
- GTBP $10.66
- Technical
- Relative Strength Index (RSI)
- GV 70.77
- GTBP 40.32
- Support Level
- GV $1.25
- GTBP $2.41
- Resistance Level
- GV $1.45
- GTBP $3.40
- Average True Range (ATR)
- GV 0.23
- GTBP 0.30
- MACD
- GV 0.10
- GTBP -0.04
- Stochastic Oscillator
- GV 58.98
- GTBP 6.09
About GV Visionary Education Technology Holdings Group Inc.
Visionary Holdings Inc is a private education providing company located in Canada, with subsidiaries in Canada and market partners in China, that offers high-quality education resources to students around the globe. The company aims to provide access to secondary, college, undergraduate and graduate, and vocational education to students in Canada through technological innovation so that more people can learn, grow, and succeed to their full potential. As a fully integrated provider of educational programs and services in Canada, the company has been serving and will continue to serve both Canadian and international students.
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.